- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2019–2024 · training · T32
Psychosocial Palliative and Community Research in Cancer
Jennifer L Hay · Kettering University · funded by National Institutes of Health
2019–2022 · fellowship · F31
Coupling metabolic pathways with pluripotent gene regulation in mouse embryonic stem cells
Paige Arnold · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Molecular mechanisms of replication-coupled chromatin assembly
Dirk Remus · Kettering University · funded by National Institutes of Health
2019–2022 · career development · K00
Compartimental bi-specific antibody and cytokine therapy for advance desmoplastic small round cell tumors
Madelyn Espinosa-Cotton · Kettering University · funded by National Institutes of Health
2019–2022 · research · R00
Regulation of tumor-associated phagocyte physiology during tumor cell clearance
Justin S Perry · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
Confocal video-mosaicking microscopy to guide surgery of superficially spreading skin cancers
Octavia Irma Camps · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Replication Of Chromosomes In Budding Yeast
Iestyn Whitehouse · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing
Michael F. Berger · Kettering University · funded by National Institutes of Health
2019–2025 · research · R01
Studies on the effects of a novel intermittent therapy on intratumoral clonal architecture and resistance
Piro Lito · Kettering University · funded by National Institutes of Health
2019–2024 · research · R35
Interrogating Protein Methyltransferases with Integrated Approaches
Minkui Luo · Kettering University · funded by National Institutes of Health
2019–2022 · research · R03
A Pilot CHW Model to Facilitate Shared Decision Making and Lung Cancer Screening for Chinese Taxi Drivers
Jennifer Cf Leng · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
Body composition and the obesity paradox in clear cell renal cell carcinoma
Anna Helena Furberg-Barnes · Kettering University · funded by National Institutes of Health
2019–2026 · research · R35
Annotating Cancer Biology through Non-Invasive Molecular Imaging
Jason S. Lewis · Kettering University · funded by National Institutes of Health
2019–2022 · career development · K00
Compartimental bi-specific antibody and cytokine therapy for advance desmoplastic small round cell tumors
Madelyn Espinosa-Cotton · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
Molecular characterization of the multi-modal regulation of inositol 1,4,5-trisphosphate receptors
Richard Kevin Hite · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Third-party “off the shelf” mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT
Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health
2019–2022 · career development · K22
Improving shared decision making in cancer screening
Sigrid Carlsson · Kettering University · funded by National Institutes of Health
2019–2021 · fellowship · F31
Therapeutic Targeting of Gaq in Uveal Melanoma
Tyler Hitchman · Kettering University · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2019–2024 · research · R50
Organic Synthesis at the Service of Biology and Medicine
Ouathek Ouerfelli · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Third-party “off the shelf” mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT
Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
Robert Andrew Cramer · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’
Dinshaw J Patel · Kettering University · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
Carol Aghajanian · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT)
Ying Taur · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health
2019–2024 · research · R01
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis
Michael S Glickman · Kettering University · funded by National Institutes of Health
2019–2022 · grant · Flint Area / Revitalizing the Education Continuum
Learning Commons
Kettering University · funded by Charles Stewart Mott Foundation
2019–2024 · research · R25
MSK Computational Biology Summer Program
Michael F. Berger · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
Robert Andrew Cramer · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Regulation of replication and recombination intermediates
Xiaolan Zhao · Kettering University · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging
Wesley E Bolch · Kettering University · funded by National Institutes of Health
2019–2024 · research · R50
Organic Synthesis at the Service of Biology and Medicine
Ouathek Ouerfelli · Kettering University · funded by National Institutes of Health
2019–2022 · research · R01
Mechanisms of COPII-Dependent Quality Control and ER Export
Jonathan D Goldberg · Kettering University · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
Carol Aghajanian · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Regulation of y-secretase activity by modulatory proteins
Yueming Li · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Third-party “off the shelf” mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT
Marcel R M Van Den Brink · Kettering University · funded by National Institutes of Health
2019–2023 · research · R01
Regulation of Replication and Recombination Intermediates
Xiaolan Zhao · Kettering University · funded by National Institutes of Health
2019–2021 · research · R01
Enhancement of T cell therapy by incorporating adjunct treatment strategies
Ronald George Blasberg · Kettering University · funded by National Institutes of Health
2019–2024 · research · R35
Interrogating Protein Methyltransferases with Integrated Approaches
Minkui Luo · Kettering University · funded by National Institutes of Health